LiHZhengSLiuFLiuWZhaoR. Fighting against COVID-19: innovative strategies for clinical pharmacists. Res Soc Adm Pharm. 2020;17(1):1813-1818.
2.
LiuSLuoPTangM, et al. Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm. 2020;42(2):299-304.
3.
WHO Coronavirus disease (COVID-19) Dashboard. Accessed November 22, 2020. https://covid19.who.int/
4.
BukhariNRasheedHNayyerBBabarZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13:8.
5.
AruruMTruongHAClarkS. Pharmacy Emergency Preparedness and Response (PEPR) framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Soc Adm Pharm. 2020;17(1): 1967-1977.
6.
FIP Health Advisory. Covid-19: guidelines for pharmacists and the pharmacy workforce. Accessed June 08, 2020. https://www.fip.org
7.
LiLChenNKongLM, et al. Antiviral therapeutics for 2019 novel coronavirus infection in special populations. Chin J Mod Appl Pharm. 2020;37(3):257-263.
8.
LiGDe ClercqE. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19:149-150.
9.
LiuYSuNShenChao, et al. Literature analysis on the efficacy and safety of lopinavir/ritonavir in viral infectious diseases. Herald Med. 2020;39(5):621-627.
10.
ZhaoJPHuYDuRH, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Chin J Tuberc Respir Dis. 2020;43: E007-E007.
